Sun Pharma to Acquire Organon for $11.75 Billion in India’s Largest Pharma Overseas Deal
Sun Pharmaceutical Industries has agreed to purchase U.S. drugmaker Organon & Co in an all-cash transaction valued at about $11.75 billion including debt. The acquisition, financed with cash and committed bank loans, is aimed at boosting Sun's footprint in specialty medicines and women's health while providing global scale and a cash-generating bus…